These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35713319)

  • 1. Contribution of rare mutational outcomes to broadly neutralizing antibodies.
    Feng A; Hao Q; Yeap LS
    Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(6):820-827. PubMed ID: 35713319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.
    Sacks D; Wiehe K; Morris L; Moore PL
    J Virol; 2022 May; 96(10):e0027022. PubMed ID: 35510865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
    Jardine JG; Sok D; Julien JP; Briney B; Sarkar A; Liang CH; Scherer EA; Henry Dunand CJ; Adachi Y; Diwanji D; Hsueh J; Jones M; Kalyuzhniy O; Kubitz M; Spencer S; Pauthner M; Saye-Francisco KL; Sesterhenn F; Wilson PC; Galloway DM; Stanfield RL; Wilson IA; Burton DR; Schief WR
    PLoS Pathog; 2016 Aug; 12(8):e1005815. PubMed ID: 27560183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of Antibody-Dependent Cellular Cytotoxicity and Phagocytosis in Anti-HIV-1 Human-Bovine Chimeric Broadly Neutralizing Antibodies.
    Edwards JM; Heydarchi B; Khoury G; Salazar-Quiroz NA; Gonelli CA; Wines B; Hogarth PM; Kristensen AB; Parsons MS; Purcell DFJ
    J Virol; 2021 Jun; 95(13):e0021921. PubMed ID: 33853957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The affinity maturation, characteristics and application of HIV-1 broadly neutralizing antibodies].
    Wan XR; Sun M; Li Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):225-232. PubMed ID: 35184454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Junctional and somatic hypermutation-induced CX
    Yi C; Xia J; He L; Ling Z; Wang X; Yan Y; Wang J; Zhao X; Fan W; Sun X; Zhang R; Ye S; Zhang R; Xu Y; Ma L; Zhang Y; Zhou H; Huang Z; Niu J; Long G; Lu J; Zhong J; Sun B
    Cell Mol Immunol; 2021 Mar; 18(3):675-685. PubMed ID: 32235917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.
    Moore PL; Gorman J; Doria-Rose NA; Morris L
    Immunol Rev; 2017 Jan; 275(1):217-229. PubMed ID: 28133797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.
    Hwang JK; Wang C; Du Z; Meyers RM; Kepler TB; Neuberg D; Kwong PD; Mascola JR; Joyce MG; Bonsignori M; Haynes BF; Yeap LS; Alt FW
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8614-8619. PubMed ID: 28747530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of DNA lesion and repair during antibody somatic hypermutation.
    Hao Q; Li J; Yeap LS
    Sci China Life Sci; 2024 Nov; 67(11):2344-2353. PubMed ID: 39048716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?
    Burke MJ; Stockley PG; Boyes J
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32331321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Unusual Genetics and Biochemistry of Bovine Immunoglobulins.
    Stanfield RL; Haakenson J; Deiss TC; Criscitiello MF; Wilson IA; Smider VV
    Adv Immunol; 2018; 137():135-164. PubMed ID: 29455846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5.
    Azoitei ML; Ban YA; Kalyuzhny O; Guenaga J; Schroeter A; Porter J; Wyatt R; Schief WR
    Proteins; 2014 Oct; 82(10):2770-82. PubMed ID: 25043744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity landscapes constrain the evolution of broadly neutralizing anti-influenza antibodies.
    Phillips AM; Lawrence KR; Moulana A; Dupic T; Chang J; Johnson MS; Cvijovic I; Mora T; Walczak AM; Desai MM
    Elife; 2021 Sep; 10():. PubMed ID: 34491198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
    McGregor J; Hardy JM; Lay CS; Boo I; Piontek M; Suckow M; Coulibaly F; Poumbourios P; Center RJ; Drummer HE
    J Virol; 2022 Mar; 96(5):e0167521. PubMed ID: 34986001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.
    Jardine JG; Ota T; Sok D; Pauthner M; Kulp DW; Kalyuzhniy O; Skog PD; Thinnes TC; Bhullar D; Briney B; Menis S; Jones M; Kubitz M; Spencer S; Adachi Y; Burton DR; Schief WR; Nemazee D
    Science; 2015 Jul; 349(6244):156-61. PubMed ID: 26089355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
    LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC
    PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding.
    Julien JP; Huarte N; Maeso R; Taneva SG; Cunningham A; Nieva JL; Pai EF
    J Virol; 2010 May; 84(9):4136-47. PubMed ID: 20147404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All eyes on the next generation of HIV vaccines: strategies for inducing a broadly neutralizing antibody response.
    Ahlers JD
    Discov Med; 2014 Apr; 17(94):187-99. PubMed ID: 24759623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.